Financial News
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
2,148 articles
Amgen Inc. $AMGN Shares Purchased by AIA Group Ltd
AIA Group Ltd grew its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 61.6% during the third quarter, according to its most...
Amgen Inc. $AMGN Shares Purchased by AIA Group Ltd
AIA Group Ltd grew its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 61.6% during the third quarter, according to its most...
BeOne Medicines Ltd. – Sponsored ADR $ONC Shares Bought by AIA Group Ltd
AIA Group Ltd raised its stake in BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC – Free Report) by 31.4% in the 3rd quarter, according...
Achmea Investment Management B.V. Acquires 201,826 Shares of Pfizer Inc. $PFE
Achmea Investment Management B.V. lifted its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 62.1% in the third quarter, according...
Achmea Investment Management B.V. Acquires 201,826 Shares of Pfizer Inc. $PFE
Achmea Investment Management B.V. lifted its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 62.1% in the third quarter, according...
Johnson & Johnson $JNJ Shares Purchased by Achmea Investment Management B.V.
Achmea Investment Management B.V. increased its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 21.7% during the 3rd...
Johnson & Johnson $JNJ Shares Purchased by Achmea Investment Management B.V.
Achmea Investment Management B.V. increased its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 21.7% during the 3rd...
Achmea Investment Management B.V. Has $84.36 Million Stock Position in AbbVie Inc. $ABBV
Achmea Investment Management B.V. grew its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 1.6% in the third quarter, according to the...
Achmea Investment Management B.V. Has $84.36 Million Stock Position in AbbVie Inc. $ABBV
Achmea Investment Management B.V. grew its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 1.6% in the third quarter, according to the...
Academy Capital Management Makes New $12.91 Million Investment in Zoetis Inc. $ZTS
Academy Capital Management purchased a new position in shares of Zoetis Inc. (NYSE:ZTS – Free Report) during the 3rd quarter, according to the...
Academy Capital Management Makes New $12.91 Million Investment in Zoetis Inc. $ZTS
Academy Capital Management purchased a new position in shares of Zoetis Inc. (NYSE:ZTS – Free Report) during the 3rd quarter, according to the...
Serina Therapeutics (SER) Stock Surges Over 39% After Hours— Here's Why
Serina Therapeutics Inc. (NYSE:SER) jumped 39.45% in after-hours trading on Wednesday, climbing to $1.78, after the clinical-stage company announced...
Genmab A/S Teases 2026 Wave of Registrational Readouts for EPKINLY, Rina-S and Petosemtamab
Genmab A/S (NASDAQ:GMAB) executives outlined a slate of late-stage clinical catalysts expected in 2026, highlighting multiple potentially...
Genmab A/S Touts Strong 2025, Teases Catalyst-Heavy 2026 With Potential 2027 Launches
Genmab A/S (NASDAQ:GMAB) executives highlighted a “very strong year” in 2025 and outlined a catalyst-heavy 2026 that could set up multiple launches...
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Average Recommendation of “Moderate Buy” by Brokerages
Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO – Get Free Report) have earned a consensus rating of “Moderate Buy” from the...
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Consensus Rating of “Moderate Buy” from Brokerages
IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Free Report) has received a consensus rating of “Moderate Buy” from the ten analysts...
STERIS plc (NYSE:STE) Receives Average Rating of “Moderate Buy” from Analysts
STERIS plc (NYSE:STE – Get Free Report) has earned an average rating of “Moderate Buy” from the eight ratings firms that are...
Novo Nordisk A/S (NYSE:NVO) Coverage Initiated by Analysts at Sanford C. Bernstein
Sanford C. Bernstein began coverage on shares of Novo Nordisk A/S (NYSE:NVO – Free Report) in a research report sent to investors on Wednesday,...
No 'SaaS Apocalypse:' Evercore Founder Dismisses AI Market Fears, Says US Economy Is Resilient Despite Iran War Even As MSFT Drops 19% In 2026
Despite the unpredictable wildcard of an Iran war and concerns regarding software companies amid the rapid rise of fears around artificial...
BioLife Solutions, Inc. (NASDAQ:BLFS) Given Consensus Recommendation of “Moderate Buy” by Brokerages
BioLife Solutions, Inc. (NASDAQ:BLFS – Get Free Report) has been assigned an average rating of “Moderate Buy” from the five...
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Consensus Rating of “Moderate Buy” by Analysts
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) has been assigned an average rating of “Moderate Buy” from the nine...
Option Care Health, Inc. (NASDAQ:OPCH) Receives Consensus Rating of “Moderate Buy” from Brokerages
Option Care Health, Inc. (NASDAQ:OPCH – Get Free Report) has earned an average recommendation of “Moderate Buy” from the eleven...
Spectral AI (NASDAQ:MDAI) Shares Down 6.3% – Here’s What Happened
Spectral AI, Inc. (NASDAQ:MDAI – Get Free Report)’s stock price was down 6.3% during trading on Wednesday . The stock traded as low as...
TriSalus Life Sciences (NASDAQ:TLSIW) Shares Up 18.2% – Here’s Why
TriSalus Life Sciences, Inc. (NASDAQ:TLSIW – Get Free Report)’s share price rose 18.2% during mid-day trading on Wednesday . The company...
Can-Fite BioPharma (NYSE:CANF) Trading Up 0.3% – Still a Buy?
Can-Fite BioPharma Ltd. (NYSE:CANF – Get Free Report)’s stock price shot up 0.3% on Wednesday . The stock traded as high as $3.53 and...
CytomX Therapeutics (NASDAQ:CTMX) Sees Large Volume Increase After Analyst Upgrade
CytomX Therapeutics, Inc. (NASDAQ:CTMX – Get Free Report) shares saw an uptick in trading volume on Wednesday after Jefferies Financial Group...
Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX)
Forte Biosciences, Inc. (NASDAQ:FBRX – Get Free Report) saw some unusual options trading activity on Wednesday. Investors purchased 30,205 call...
Tactile Systems Technology, Inc. (NASDAQ:TCMD) Receives Consensus Rating of “Moderate Buy” from Analysts
Shares of Tactile Systems Technology, Inc. (NASDAQ:TCMD – Get Free Report) have been given a consensus rating of “Moderate Buy” by...
LifeStance Health Group, Inc. (NASDAQ:LFST) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) have earned an average rating of “Moderate Buy” from the...
PolyPid Ltd. (NASDAQ:PYPD) Receives Consensus Recommendation of “Moderate Buy” from Analysts
PolyPid Ltd. (NASDAQ:PYPD – Get Free Report) has received an average recommendation of “Moderate Buy” from the six research firms...
Editas Medicine, Inc. (NASDAQ:EDIT) Receives Consensus Rating of “Moderate Buy” from Analysts
Shares of Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eight...
Vivos Therapeutics (NASDAQ:VVOS) Trading 1.5% Higher – Should You Buy?
Vivos Therapeutics, Inc. (NASDAQ:VVOS – Get Free Report) shares traded up 1.5% during trading on Wednesday . The company traded as high as...
DIAGNOS (OTCMKTS:DGNOF) Trading Up 2.6% – Time to Buy?
Shares of DIAGNOS Inc. (OTCMKTS:DGNOF – Get Free Report) shot up 2.6% during trading on Wednesday . The stock traded as high as $0.2145 and...
Medartis Holding AG (OTCMKTS:MDRSF) Short Interest Down 12.8% in February
Medartis Holding AG (OTCMKTS:MDRSF – Get Free Report) saw a significant decrease in short interest in February. As of February 27th, there was...
Nykode Therapeutics AS (OTCMKTS:VACBF) Short Interest Down 14.2% in February
Nykode Therapeutics AS (OTCMKTS:VACBF – Get Free Report) was the recipient of a large decrease in short interest in February. As of February...
The Ensign Group, Inc. (NASDAQ:ENSG) Given Average Rating of “Buy” by Analysts
The Ensign Group, Inc. (NASDAQ:ENSG – Get Free Report) has been assigned a consensus recommendation of “Buy” from the seven...